A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer

Author： Gershanovich M.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.45, Iss.3, 1997-09, pp. : 251-262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison between the Effects of Tamoxifen and Toremifene on the Uterus in Postmenopausal Breast Cancer Patients

By TOMÁS E.   Kauppila A.   Blanco G.   Apaja-Sarkkinen M.   Laatikainen T.  

Gynecologic Oncology, Vol. 59, Iss. 2, 1995-11 ,pp. : 261-266

Academic Press

Access to resources Recommend Favorite

Phase III Randomized Trial of Toremifene vs Tamoxifen in Hormonodependant Advanced Breast Cancer

By Milla-Santos A.   Milla L.   Rallo L.   Solano V.  

Breast Cancer Research and Treatment, Vol. 65, Iss. 2, 2001-01 ,pp. : 119-124

Springer Publishing Company

Access to resources Recommend Favorite

Estrogenic Effects of Toremifene and Tamoxifen in Postmenopausal Breast Cancer Patients

By Ellmén J.  

Breast Cancer Research and Treatment, Vol. 82, Iss. 2, 2003-01 ,pp. : 103-111

Springer Publishing Company

Access to resources Recommend Favorite

Treatment Options For Postmenopausal Women with Tamoxifen-Resistant Advanced Breast Cancer

By Cheung K-L.   Robertson J.F.R.  

American Journal of Cancer, Vol. 1, Iss. 4, 2002-01 ,pp. : 293-300

Adis International

Access to resources Recommend Favorite

Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study

By Aihara Tomohiko  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 379-387

Springer Publishing Company

Access to resources Recommend Favorite